Category: New products
-
Bayer Gains Lung Cancer Therapy in $670M Deal
Global drug maker Bayer AG is licensing an engineered T-cell therapy to treat mesothelioma and other solid tumor cancers from biotech Atara Biotherapeutics.
-
Small Biz Grant Funds AI Repro Health Technology
A company developing health metrics with artificial intelligence received a grant to better understand polycystic ovary syndrome, an endocrine disorder affecting women.
-
Start-Up Creating Digital Therapies for Alzheimer’s
A new enterprise is developing personalized digital therapeutics for people with Alzheimer’s disease and other neurodegenerative disorders.
-
Inexpensive Chip Detects Covid-19, Other Pathogens
A small silicon lab-on-a-chip device costing about $0.35 to make is shown in lab tests to quickly detect SARS-CoV-2 viruses and infectious bacteria.
-
Industry, Univ Labs Partner on Cannabinoid Pain Drug
A Canadian medical school lab is helping evaluate and develop a pain relief drug made by a company developing therapies from cannabis.
-
Simpler Method Devised to Validate Covid-19 Tests
An engineering lab created simple and stable control probes to validate widely used diagnostic tests for SARS-Cov-2 viruses responsible for Covid-19.
-
Crispr Edits Out HIV-Like Genes from Monkey DNA
Researchers show the gene-editing technique Crispr can remove genes gained from infections similar to HIV in lab monkeys, as well as viral signals from their bodies.
-
Univ, Industry Labs Study Inhaled Covid-19 Antibodies
Researchers at University of Pennsylvania and Regeneron are studying delivery of synthetic antibodies directly to the nose to prevent Covid-19 infections.
-
Biotech Creating More Efficient Crispr Therapies
A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins.
-
Trial Requested for Covid-19 Vaccine Nasal Spray
Makers of a Covid-19 vaccine given as a nasal spray asked the Food and Drug Administration to authorize a a human clinical trial of the vaccine.